New drug SPY001-001 tested in healthy people for first time
Knowledge-focused
Completed
This early-phase trial tested the safety and tolerability of a new drug called SPY001-001 in 96 healthy volunteers. Participants received either the drug or a placebo, and researchers monitored side effects and how the drug moves through the body. Since this is a first-in-human s…
Phase: PHASE1 • Sponsor: Spyre Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC